Your Source for Venture Capital and Private Equity Financings

Venture Capital News: ImmuneID Inks $50M Series A

2021-06-23
CAMBRIDGE, MA, ImmuneID, a precision immunology company, has raised $50 million in Series A financing led by Alta Partners.
CAMBRIDGE, MA, ImmuneID, a precision immunology company, has raised $50 million in Series A financing.

This Series A round was led by new investor Alta Partners and included new investors Alexandria Venture Investments, Redwood Capital Investments, Section 32 and Tekla Capital Management. All existing investors participated in the financing, including Arch Venture Partners, Longwood Fund, Pitango HealthTech, In-Q-Tel, Xfund and others. This Series A financing follows a $22 million seed financing round that was led by founding investor Longwood Fund.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors